The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation (Q34768066)

4 August 2017

1 reference

title

The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation (English)

1 reference

4 August 2017

main subject

liver transplantation

1 reference

Raymund R Razonable

1 reference

4 August 2017

Carlos V Paya

series ordinal

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

published in

Liver Transplantation

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

651-658

1 reference

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Primary Human Herpesvirus 6 Infection in Young Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus-6 infection in children. A prospective study of complications and reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Genetic content of a 20.9 kb segment of human herpesvirus 6B strain Z29 spanning the homologs of human herpesvirus 6A genes U40-57 and containing the origin of DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Isolation of a new herpesvirus from human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus-6 and -7 in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Prevalence of antibody to human herpesvirus 7 by age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Fever in liver transplant recipients: changing spectrum of etiologic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus-6 infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human beta-herpesvirus interactions in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus type 7 in blood donors: detection by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesviruses 6 and 7 in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Neuroinvasion and persistence of human herpesvirus 6 in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

"Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

CD46 is a cellular receptor for human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Infection of natural killer cells by human herpesvirus 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

Comparison of antiviral compounds against human herpesvirus 6 and 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34966

21 January 2018

Identifiers

DOI

10.1053/JLTS.2002.34966

1 reference

4 August 2017

1 reference